SCHEMBL7688982

SCHEMBL7688982

NC(=O)N(c1ccccc1Br)c1ccc(Cl)c(S(=O)(=O)N2CCOCC2)c1O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.42
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPT P10636 2/20 0.38
HTT P42858 1/20 0.38
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
USP2 O75604 1/20 0.38
CREBBP Q92793 1/20 0.38
MAPK1 P28482 1/20 0.38
CNR1 P21554 3/20 0.37
CXCR2 P25025 2/20 0.37
POLB P06746 3/20 0.37
RXFP1 Q9HBX9 1/20 0.37
TP53 P04637 1/20 0.37
RAB9A P51151 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GAA P10253 1/20 0.36
ATM Q13315 1/20 0.36
CXCR1 P25024 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27571760 0.91 CXCR2 (0.45) HTTSMN1; SMN2MAPK1CNR1CXCR2
SCHEMBL7542421 0.89 CXCR2 (0.39) HTTLMNASMN1; SMN2CNR1CXCR2
SCHEMBL27571705 0.86 CXCR2 (0.36) PKMKMT2ACNR1CXCR2ATM
SCHEMBL8002618 0.83 CXCR2 (0.35) CNR1CXCR2ATMCXCR1
SCHEMBL27608152 0.82 CXCR2 (0.51) CXCR2CXCR1
SCHEMBL7118983 0.81 CXCR2 (0.43) MEN1KMT2ASMN1; SMN2CNR1CXCR2
SCHEMBL27552241 0.78 PLAU (0.39) CXCR2CXCR1
SCHEMBL6550852 0.78 CXCR2 (0.41) CXCR2CXCR1
SCHEMBL27552112 0.77 CASP3 (0.37) MEN1KMT2ACXCR2CXCR1ALDH1A1
SCHEMBL7501094 0.77 CXCR2 (0.44) KMT2ALMNACNR1CXCR2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6500863-B1 INTERLEUKIN BINDING INHIBITORS SUCH AS N-(2-HYDROXYL-3-AMINO SULFONYL-4-CHLOROPHENYL)-N'-(2-BROMOPHENYL)UREA, USED FOR PROPHYLAXIS OF CHEMOKINE MEDIATED DISEASES SMITHKLINE BEECHAM CORPORATION 2002-12-31 US disclosed